NIH describes antidepressant use in selected mental-health settings; confirm current availability and the specific indication.
Profile scope: Maprotiline reference. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Sleepiness, dry mouth, bowel changes, weight changes, or blurred vision may occur.
Serious risks and warning signs
Suicidal thoughts or major behavioral changes require immediate advice, particularly early in treatment or around dose changes. Abnormal rhythm, severe movement symptoms, infection, or jaundice also needs prompt assessment.
A question for your healthcare team
What mood, heart, and other monitoring applies, and how would treatment be adjusted safely?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.